Abstract
The FHIT (fragile histidine triad) gene located at chromosome region 3p14 has been reported to be deleted in a variety of common tumors including esophageal carcinoma
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3, 8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587–597
Inoue H, Ishii H, Alder H, Snyder E, Druck T, Huebner K, Croce CM (1997) Sequence of the FRA3B common fragile region: implications for the mechanisms of FHIT deletion. Proc Natl Acad Sci USA 94:14584–14589
Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M, Huebner K, Croce CM (1999) Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci USA 96:7456–7461
Michael D, Beer DG, Wilke CW, Miller DE, Glover TW (1997) Frequent deletions of FHIT and FRA3B in Barrett’s metaplasia and esophageal adenocarcinomas. Oncogene 15:1653–1659
Nelson HN, Wieneke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT (1998) Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos, Cancer Res 58:1804–1807
Morita M, Kuwano H, Ohno S, Sugimachi K, Seo Y, Tomoda H, Furusawa M, Nakashima T (1994) Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int J Cancer 58:207–210
Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S (1998) Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58:5032–5037
Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD, Jr, Chen LB (1993) Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 8:2821–2826
Campiglio M, Pekarsky Y, Menard S, Tagliabue E, Pilotti S, Croce CM (1999) FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. Cancer Res 59:3866–3869
Ishi H, Baffa R, Numata S, Murakumo Y, Rattan S, Inoue H, Mori M, Fidanza V, Alder H, Croce CM (1999) The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Nat! Acad Sci USA 96:3923–3933
Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K (1998) Loss of FHIT expression in gastric carcinoma. Cancer Res, 58:4708–4714
Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K (1997) Replacement of FHIT in cancer cells suppress tumorigenicity. Proc Nat! Acad Sci USA 94:13771–13776
Sugimachi K (1998) Advances in the surgical treatment of oesophageal Cancer. Br J Surg 85:289–290
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Japan
About this paper
Cite this paper
Mori, M., Mimori, K., Inoue, H., Tanaka, Y., Huebner, K., Croce, C.M. (2002). Altered Expression of FHIT in Esophageal Neoplasm. In: Imamura, M. (eds) Superficial Esophageal Neoplasm. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67873-1_24
Download citation
DOI: https://doi.org/10.1007/978-4-431-67873-1_24
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67997-4
Online ISBN: 978-4-431-67873-1
eBook Packages: Springer Book Archive